Details
| Stereochemistry | EPIMERIC |
| Molecular Formula | C17H24NO3.NO3 |
| Molecular Weight | 352.3823 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 3 / 5 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[O-][N+]([O-])=O.C[N+]1(C)[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C(O)C3=CC=CC=C3
InChI
InChIKey=DRTHYWDOFIVHKK-RIMUKSHESA-N
InChI=1S/C17H24NO3.NO3/c1-18(2)13-8-9-14(18)11-15(10-13)21-17(20)16(19)12-6-4-3-5-7-12;2-1(3)4/h3-7,13-16,19H,8-11H2,1-2H3;/q+1;-1/t13-,14+,15+,16?;
DescriptionSources: https://www.drugs.com/pro/hydromet.html
Sources: https://www.drugs.com/pro/hydromet.html
Homatropine methylbromide or Methylhomatropine bromide is a quaternary ammonium salt of methylhomatropine. It is a peripherally acting anticholinergic medication that inhibits muscarinic acetylcholine receptors and thus the parasympathetic nervous system. Certain preparations of drugs such as hydrocodone are mixed with a small, sub-therapeutic amount of homatropine methylbromide to discourage intentional overdose.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL2094109 Sources: https://www.ncbi.nlm.nih.gov/pubmed/6135619 |
350.0 nM [Ki] |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
Sources: http://www.ndrugs.com/?s=paratropina |
Primary | PARATROPINA Approved UseFor spasmodic pains & disorders of the GIT eg irritable colon, mucous colitis, colicky pains, peptic ulcer, pylorospasm, cardiospasm, flatulence, nausea, vomiting & hyperacidity |
Sample Use Guides
In Vivo Use Guide
Sources: http://www.paratropina.com.ar/como-se-toma.php
Oral administration: 40 drops of paratropin should be dissolved in a glass of water and administered orally.
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/6135619
The brains from SD rats were removed following decapitation, dissected free of membranes, and the cerebella discarded. Tissues were then homogenized with a Brinkmann Polytron in 20 vol of ice cold Tris-HCl buffer (50 mM, pH 7.7). The homogenates were centrifuged at 40000 × g for 10 min at 4°C and the pellets resuspended in the buffer at a concentration of 50 mg wet weight/ml. Radioligand displacement binding studies were performed using 0.06 nM of [3H]QNB and 0.2-0.4 mg protein. The Kd value for [3H]QNB was previously determined in our laboratory to be 0.1 nM. Analysis of the results was performed as described above. Methylhomatropine displaces radioligand with Ki of 350 nM.
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
60539-03-9
Created by
admin on Mon Mar 31 22:08:54 GMT 2025 , Edited by admin on Mon Mar 31 22:08:54 GMT 2025
|
PRIMARY | |||
|
SUB72785
Created by
admin on Mon Mar 31 22:08:54 GMT 2025 , Edited by admin on Mon Mar 31 22:08:54 GMT 2025
|
PRIMARY | |||
|
6CG939TH70
Created by
admin on Mon Mar 31 22:08:54 GMT 2025 , Edited by admin on Mon Mar 31 22:08:54 GMT 2025
|
PRIMARY | |||
|
DTXSID90975950
Created by
admin on Mon Mar 31 22:08:54 GMT 2025 , Edited by admin on Mon Mar 31 22:08:54 GMT 2025
|
PRIMARY | |||
|
100000135957
Created by
admin on Mon Mar 31 22:08:54 GMT 2025 , Edited by admin on Mon Mar 31 22:08:54 GMT 2025
|
PRIMARY | |||
|
18850-17-4
Created by
admin on Mon Mar 31 22:08:54 GMT 2025 , Edited by admin on Mon Mar 31 22:08:54 GMT 2025
|
SUPERSEDED |
ACTIVE MOIETY
SUBSTANCE RECORD